Release Date: 21/12/22 10:30 Summary: Hancock Energy Fourth Supplementary Bidder's Statement Price Sensitive: Yes Download Document 498.94KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%